Name
Seeing Through the Weight Loss Revolution: GLP-1s and Ocular Health
Description
GLP-1 receptor agonists have quickly become some of the most widely prescribed drugs in the United States. This course reviews how these drugs work and the evidence linking them to early worsening of diabetic retinopathy, NAION, neovascular AMD and other ocular effects, including current FDA, EMA and WHO regulatory positions. It gives attendees a practical approach to baseline exams, follow-up, counseling, referral and co-management with prescribers.
Speakers
April Jasper
Presentation Authors
April Jasper, OD
Date & Time
Thursday, March 4, 2027, 11:15 AM - 12:15 PM